Insiders SynAct Pharma AB

Equities

SYNACT

SE0008241491

Delayed Nasdaq Stockholm Other stock markets 02:36:01 16/05/2024 pm IST			5-day change	1st Jan Change
7.07 ^SEK	-1.81%		-0.63%	-19.93%

23/04	Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting	CI
20/03	Sweden's SynAct Pharma Names New CEO	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting	23/04	CI
Sweden's SynAct Pharma Names New CEO	20/03	MT
SynAct Pharma AB Elects New Board Members and Chairman at Extraordinary General Meeting	20/03	CI
SynAct Pharma AB Announces CEO Changes	20/03	CI
SynAct Pharma AB Announces Resignation of Marina Bozilenko as Member of the Board of Directors	27/02	CI
SynAct Pharma Names New Chief Medical Officer	01/02	MT
Synact Pharma Appoints Kristen Harting as Chief Medical Officer, Effective 15 February 2024	01/02	CI
Synact Pharma Expands Its Rheumatology Clinical Advisory Board with Three New Highly Experienced Advisors	30/01	CI
SynAct Pharma AB Announces Appointments to Nomination Committee	22/11	CI
SynAct Pharma AB Announces Appointment of Thomas Von Koch as Board Member	25/23/25	CI
SynAct Pharma AB Appoints Björn Westberg as Chief Financial Officer	15/23/15	CI
SynAct Pharma AB Announces Executive Changes	03/23/03	CI
SynAct Pharma AB Introduces Resomelagon as Generic Name for AP1189	30/23/30	CI
Synact Pharma AB Announces Resignation of Patrik Renblad as Chief Financial Officer	01/23/01	CI
Change in Nomination Committee prior to AGM 2023 in SynAct Pharma	22/22/22	AQ
SynAct Pharma AB Announces Change in Nomination Committee Prior to Agm 2023	22/22/22	CI
Nomination Committee appointed ahead of AGM 2023 in SynAct Pharma AB	21/22/21	AQ
John Haurum Declines Re-Election as Board Member of SynAct Pharma AB	20/22/20	CI
The Nomination Committee proposes Kerstin Hasselgren as a new board member of SynAct Pharma AB	09/22/09	AQ
Synact Pharma Promotes Finance Vice President To CFO	07/22/07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders SynAct Pharma AB

Equities

SYNACT

SE0008241491

Insiders

Filters